Our aim is to produce safe and effective vaccines to protect every child in the world against a wide spectrum of diseases.
GSBPL has taken under its wings experienced scientists, entered into JVs and partnerships to ensure new production facilities with the main goal of providing cost effective, high quality vaccines.
GSBPL provides cell lysates, DNA, and protein extracts from various Bacterial and viral strains. Our strength lies in the ability of our scientists to provide custom research services to their clients.
BCG 40 for immunotherapy against urinary bladder cancer is under development. GSBPL is currently working on manufacturing plants for MMR, Rubella and other vaccines
Safety is our priorty!
Vaccine Research 
BCG 40 is in the pipeline